Category: GeoVax
-
EF Hutton maintains stock target on GeoVax amid Mpox outbreak By Investing.com
•
On Monday, EF Hutton reiterated its buy rating on shares of GeoVax Labs Inc. (NASDAQ:NASDAQ:) with a hold price target of $18.00. The company’s endorsement comes as GeoVax is actively developing the Modified Vaccinia Ankara (MVA) vaccine to combat the outbreak of smallpox virus type 1 in the Democratic Republic…